THC–Morphine Coadministration Increased Tolerance Without Clearly Changing Withdrawal in Monkeys

Combining THC with morphine did not move every opioid-related outcome in the same direction. In a small rhesus-monkey experiment, antinociceptive tolerance was greater with the combination while withdrawal after discontinuation was generally similar.

The experiment involved four monkeys

Animals received repeated morphine alone or with THC. Researchers measured warm-water tail-withdrawal responses to several agonists before, during and after treatment. They separately monitored cardiovascular and directly observable withdrawal signs when treatment stopped.

Tolerance changed more than withdrawal

The abstract reports larger rightward and downward shifts in antinociceptive dose-response curves during combined treatment than during morphine alone. After discontinuation, heart rate and observable withdrawal signs increased, but concurrent THC did not markedly alter the withdrawal pattern.

Enhanced acute effects do not settle repeated-treatment outcomes

A combination can increase the potency of an acute analgesic effect without reducing later tolerance or dependence. Those are different questions with different experimental measurements.

The sample was very small and the endpoint was an animal reflex, not a clinical pain score. The result does not determine a person's medication needs or establish whether a human combination is safer. It also differs from experiments asking whether morphine exposure alone changes later cannabinoid sensitivity. Keeping coadministration and exposure-history questions separate prevents conflicting-looking findings from being treated as interchangeable evidence.

Related: interpreting cannabis tolerance claims.

Research cited

Gerak LR; France CP. Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal. The Journal of pharmacology and experimental therapeutics (2016). doi:10.1124/jpet.115.231381. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Clomipramine Challenge Linked Withdrawal-Like Behavior and Histamine Changes in THC-Tolerant Rats

A 1985 rat experiment reported withdrawal-like behavior and regional histamine decreases after clomipramine challenge in THC-tolerant animals. The design was a pharmacological challenge, not simply observation after THC cessation. Tolerance was established before the challenge Repeated intravenous THC produced tolerance to cooling and to the acute regional histamine reductions over…

Spread the love

Read Article: A Clomipramine Challenge Linked Withdrawal-Like Behavior and Histamine Changes in THC-Tolerant Rats

A Mouse Study Found Persistent Electrical Hyperexcitability Despite Tolerance to THC Motor Effects

A 1986 mouse study reported prolonged susceptibility to electrically induced convulsions after THC, while repeated treatment produced tolerance to motor toxicity but not that excitability endpoint. Adaptation differed between visible movement effects and a later electrical challenge. The exposure was a high-dose injected protocol The experiment examined a wide high-dose…

Spread the love

Read Article: A Mouse Study Found Persistent Electrical Hyperexcitability Despite Tolerance to THC Motor Effects

Prior THC Exposure Changed Whether Environmental Familiarity Mattered in a Rat Study

A 1987 rat experiment found environmental familiarity affected THC behavior in drug-naive animals but not in animals previously exposed to THC. The finding was an interaction between two histories, not proof that context never matters. Drug and chamber exposure were separated Four groups received prior drug exposure, prior chamber exposure,…

Spread the love

Read Article: Prior THC Exposure Changed Whether Environmental Familiarity Mattered in a Rat Study

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us